Mark Evans
Clinical Genetics (M.D.) New York, NY Medical Doctor
NPI 1497891675 CMS profile 861104
131 E 65Th St, 2906, New York, NY 10021
General payments
$588
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Mark Evans of New York, NY is reported in the CMS Open Payments database as having received $588 across 7 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 55th percentile of Clinical Genetics (M.D.) profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $222 | 3 | |
| 2024 | General | $171 | 2 | |
| 2019 | General | $195 | 2 |
Beside peers
- Mark Evans
- Clinical Genetics (M.D.) median
- Middle half of Clinical Genetics (M.D.)
- National median
In program year 2025, general payments to Mark Evans were reported at $222. Among 315 Clinical Genetics (M.D.) profiles paid that year, the median was $255 and the middle half received between $85 and $3,583.
Show as a table
| Year | Mark Evans | Clinical Genetics (M.D.) median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $195 | $130 | $24–$2,691 | $163 |
| 2020 | $0 | $126 | $30–$3,700 | $114 |
| 2021 | $0 | $185 | $30–$3,777 | $132 |
| 2022 | $0 | $136 | $44–$2,749 | $149 |
| 2023 | $0 | $196 | $55–$5,220 | $160 |
| 2024 | $171 | $165 | $46–$3,171 | $164 |
| 2025 | $222 | $255 | $85–$3,583 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
7 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Clinical Genetics (M.D.) in New York
Robert Desnick
Clinical Genetics (M.D.) · New York, NY
Manisha Balwani
Clinical Genetics (M.D.) · New York, NY
David Kronn
Clinical Genetics (M.D.) · Valhalla, NY
Jaya Ganesh
Clinical Genetics (M.D.) · New York, NY
Berrin Monteleone
Clinical Genetics (M.D.) · Mineola, NY
George Diaz
Clinical Genetics (M.D.) · New York, NY
Related records
Clinical Genetics (M.D.) in New York
Practitioners in the same specialty and state, ranked by reported value.
All Clinical Genetics (M.D.)
Everyone recorded under this specialty, nationwide.
Doctors in New York
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.